Virginia Retirement Systems’s Cytokinetics CYTK Stock Holding History

Virginia Retirement Systems’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$630K	Buy	+7,400	New	+$531K	﹤0.01%	895
2026 Q1	–	Sell	-4,950	Closed	-$315K	–	970
2025 Q4	$315K	Buy	+4,950	New	+$308K	﹤0.01%	839
2020 Q2	–	Sell	-10,700	Closed	-$126K	–	1109
2020 Q1	$126K	Buy	+10,700	New	+$137K	﹤0.01%	1040
2018 Q3	–	Sell	-66,500	Closed	-$552K	–	1046
2018 Q2	$552K	Sell	66,500 -18,300	-22%	-$152K	0.01%	875
2018 Q1	$611K	Buy	84,800 +9,900	+13%	+$84.9K	0.01%	789
2017 Q4	$610K	Buy	+74,900	New	+$850K	0.01%	772

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virginia Retirement Systems's CYTK Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Cytokinetics (CYTK) in Q2 2026: 7,400 shares worth $630K. The stake represents ﹤0.01% of the portfolio and ranks #895 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in CYTK as recently as Q4 2025.

Virginia Retirement Systems first reported a position in CYTK in Q4 2017 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Virginia Retirement Systems held 7,400 shares of Cytokinetics worth $630K as of Q2 2026.
Cytokinetics was a new Virginia Retirement Systems position in Q2 2026.
Cytokinetics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #895 holding.
Virginia Retirement Systems first reported a position in Cytokinetics in Q4 2017 and has held it in 6 quarters since.
482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.